-
Recent Posts
- Infants TYLENOL Oral Suspension 1 oz Grape Recall
- Avastin bevacizumab Counterfeit Product
- Wholistic Herbs Inc Koff and Kold Kold Sore Spray Recall
- Victrelis and Ritonavir Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs Drug Safety Communication
- Proton Pump Inhibitors PPIs Drug Safety Communication
Categories
- Anesthesiology
- Avandia
- Cardiology
- Consumer Products
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Infectious Disease
- multiple sclerosis (MS)
- Neurology
- OBGYN
- Oncology
- Pediatrics
- Pharmacy
- Psychiatry
- Rheumatology
- Risk Manager
- Uncategorized
Tag Archives: drug risks
Infants TYLENOL Oral Suspension 1 oz Grape Recall
Infants’ TYLENOL Oral Suspension, 1 oz. Grape: Recall – Dosing System Complaints AUDIENCE: Consumer, Pharmacy ISSUE: McNeil Consumer Healthcare notified the public of a recall of seven lots (approximately 574,000 bottles) of Infants’ TYLENOL Oral Suspension, 1 oz. Grape. There … Continue reading
Posted in Consumer Products, FDA 2012, FDA Recall, Pharmacy
Tagged 1 oz Grape, Consumer, Dosing System Complaints, drug risks, FDA recall, Infants TYLENOL, Infants TYLENOL Oral Suspension 1 oz Grape Recall, McNeil Consumer Healthcare, Oral Suspension, Pharmacy, Recall, SimpleMeasure dosing system
Comments Off
Avastin bevacizumab Counterfeit Product
Avastin (bevacizumab): Counterfeit Product – FDA Issues Letters to 19 Medical Practices AUDIENCE: Oncology, Pharmacy, Patient ISSUE: The FDA is warning healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by … Continue reading
Posted in FDA 2012, FDA Warning, Oncology, Pharmacy
Tagged Avastin, Avastin bevacizumab Counterfeit Product, bevacizumab, Cancer Drugs, Counterfeit Product, drug risks, FDA warning, Genetech, Montana Health Care Solutions, Oncology, Pharmacy, Quality Specialty Products, Roche
Comments Off
Wholistic Herbs Inc Koff and Kold Kold Sore Spray Recall
Wholistic Herbs, Inc. “Koff and Kold” and “Kold Sore” Spray: Recall – Non-Sterile Products AUDIENCE: Consumer ISSUE: Wholistic Herbs Inc. notified the public it is recalling all quantities of “Koff & Kold” spray with herbal extract and “Kold Sore” spray … Continue reading
Posted in Consumer Products, FDA 2012, FDA Recall
Tagged cold remedy, Dietary Supplements, drug, drug risks, FDA recall, Koff and Kold, Kold Sore Spray, Over the counter, Recall, Wholistic Herbs Inc, Wholistic Herbs Inc Koff and Kold Kold Sore Spray Recall
Comments Off
Victrelis and Ritonavir Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs Drug Safety Communication
Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication – Drug Interactions AUDIENCE: Infectious Disease, Pharmacy ISSUE: FDA notified healthcare professionals and patients that drug interactions between the hepatitis C virus (HCV) protease inhibitor Victrelis … Continue reading
Posted in FDA 2012, FDA Notice, FDA Safety Communication, Infectious Disease, Pharmacy
Tagged drug risks, Drug Safety Communication, FDA notice, FDA warning, Human Immunodeficiency Virus (HIV), Protease Inhibitor Drugs, Victrelis (boceprevir) and Ritonavir-Boosted, Victrelis and Ritonavir Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs
Comments Off
Proton Pump Inhibitors PPIs Drug Safety Communication
Proton Pump Inhibitors (PPIs) – Drug Safety Communication: Clostridum Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs AcipHex (rabeprazole sodium) Dexilant (dexlansoprazole) Nexium (esomeprazole magnesium) Omeprazole (omeprazole) Over-the-Counter (OTC) Prevacid (lansoprazole) and OTC Prevacid 24hr Prilosec (omeprazole) and … Continue reading
Posted in Consumer Products, Family Practice, FDA 2012, FDA Notice, FDA Safety Communication, FDA Warning, Gastroenterology
Tagged Aciphex, Dexilant, drug risks, Drug Safety Communication, FDA notice, FDA Safety Communication, FDA warning, Nexium, Omeprazole, Prevacid, Prilosec, Proton Pump Inhibitors PPIs, Proton Pump Inhibitors PPIs Drug Safety Communication, PRotonix, safety label changes, stomach acid reducers, Vimovo, Zegerid
Comments Off